SC
GSK icon

Steph & Co’s GSK GSK Stock Holding History

Steph & Co’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.6K Sell
527
-320
-38% -$16.9K 0.01% 210
2026
Q1 		$46.7K Buy
847
+30
+4% +$1.63K 0.01% 201
2025
Q4 		$40.1K Buy
817
+379
+87% +$17.7K 0.01% 212
2025
Q3 		$18.9K Buy
438
+34
+8% +$1.33K 0.01% 256
2025
Q2 		$15.5K Sell
404
-13
-3% -$497 0.01% 251
2025
Q1 		$16.2K Buy
417
+90
+28% +$3.29K 0.01% 215
2024
Q4 		$11.1K Sell
327
-279
-46% -$10K ﹤0.01% 240
2024
Q3 		$24.8K Buy
606
+140
+30% +$5.73K 0.01% 208
2024
Q2 		$17.9K Buy
466
+38
+9% +$1.6K 0.01% 214
2024
Q1 		$18.3K Buy
+428
New +$17.6K 0.01% 221

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
BB
Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return
KIC
Keating Investment Counselors Delray Beach, Florida $364M AUM 22.11% 1-Year Est. Return
GHAM
Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return
AWAG
ARS Wealth Advisors Group St. Petersburg, Florida $1.28B AUM 24.51% 1-Year Est. Return
HAI
Hennessy Advisors Inc Novato, California $3.13B AUM 77.26% 1-Year Est. Return

Steph & Co's GSK Position: Q2 2026 in Review

Steph & Co reduced its GSK (GSK) stake by 38% in Q2 2026, selling an estimated $16.9K and leaving 527 shares worth $27.6K. The position accounts for 0.01% of the portfolio, ranked #210.

Steph & Co first reported a position in GSK in Q1 2024 and has held it in 10 quarters since. The position peaked at $46.7K in Q1 2026. 161 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Steph & Co held 527 shares of GSK worth $27.6K as of Q2 2026.
  • Steph & Co sold 320 GSK shares in Q2 2026, an estimated $16.9K.
  • GSK made up 0.01% of Steph & Co's portfolio in Q2 2026, its #210 holding.
  • Steph & Co first reported a position in GSK in Q1 2024 and has held it in 10 quarters since.
  • Steph & Co's GSK position peaked at $46.7K in Q1 2026.
  • 161 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Steph & Co's 13F filing for Q2 2026, filed 16 Jul 2026.